SSIEM 2023

A novel pathogenic variant m.9122T>G in MT-ATP6 presenting with neonatal hypertrophic cardiomyopathy, hyperammonemia and anaemia

Barbara Siri 1 Teresa Rizza 2 Alessandra Torraco 2 Cristiano Rizzo 1 Sara Cairoli 1 Bianca Goffredo 1 Carlo Dionisi Vici 1 Rosalba Carrozzo 2 Diego Martinelli 1
1Division of Metabolism Bambino Gesu Children Hospital IRCCS, Italy
2Laboratory of Molecular Medicine Unit of Muscular and Neurodegenerative Disorders Bambino Gesu Children Hospital IRCCS, Italy

Background

Complex V deficiency is a rare mitochondrial disease (MD) primarily caused by maternally inherited variants in MT-ATP6. The heteroplasmic mutant load of pathogenic variants mainly determine the wide phenotype from NARP (Neuropathy, Ataxia, Retinitis Pigmentosa) to Leigh syndrome.

Case study

We report a full-term neonate with a prenatal diagnosis of biventricular hypertrophy presenting at birth with hypoglycaemia and cardiogenic shock. Newborn screening (NBS) showed elevated C3, C5-OH and low C5-OH/citrulline ratio. Metabolic investigations revealed high ammonia, glutamine, alanine and low citrulline, positive allopurinol load test and urinary Krebs cycle intermediates. Axial hypotonia with cortical atrophy and lactate peak at MRS were reported. During the first 6 months, he developed hyperammonaemia, lactic acidosis and hyporegenerative anaemia and at 1 year, epileptic spasms, progressive cortical atrophy with reduced deep/subcortical white matter.

Results

The biochemical profile coupling MD and proximal urea cycle suggested complex V deficiency. Molecular investigation by Sanger sequencing revealed in leukocytes a homoplasmic new missense variant, m.9122T>G p.(Leu199Arg) in MT-ATP6. Using NGS this variant was present in patient’s fibroblasts at 93% of heteroplasmy; while, blood, urine and buccal swab of the mother were negative for this variant. Mitochondria from patient’s fibroblasts showed a reduction of complex V activity with either substrate used (succinate -87%, malate -70%, pyruvate+malate -61%) and a reduction of ATP6 subunit content.

Conclusions

Our study expanded the phenotype and genotype of mutations located in MT-APT6. In fact, the de novo variant m.9122T>G showed a peculiar phenotype with hyperammonemia and anaemia. So far hyperammonemia has been reported with m.8851T>C, m.8528T>C and m.8993T>G variants; while anaemia in mt.8969G>A change. Functional studies confirmed pathogenicity of the new variant with homoplasmic load in all tissues examined.